Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 13, 2023
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
Tue, September 12, 2023
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
Li Watsek Reiterated (BCYC) at Buy and Held Target at $65 on, Sep 12th, 2023
Li Watsek of Cantor Fitzgerald, Reiterated "Bicycle Therapeutics plc" (BCYC) at Buy and Held Target at $65 on, Sep 12th, 2023.
Li has made no other calls on BCYC in the last 4 months.
There are 3 other peers that have a rating on BCYC. Out of the 3 peers that are also analyzing BCYC, 1 agrees with Li's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Reiterated at Hold and Held Target at $42 on, Friday, August 4th, 2023
These are the ratings of the 2 analyists that currently disagree with Li
- Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $57 on, Friday, August 4th, 2023
- Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $50 on, Thursday, August 3rd, 2023
